Your browser doesn't support javascript.
loading
LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway.
Zheng, Yin-Li; Li, Lei; Jia, Yong-Xun; Zhang, Bao-Zhu; Li, Jiang-Chao; Zhu, Ying-Hui; Li, Meng-Qing; He, Jiao-Zi; Zeng, Ting-Ting; Ban, Xiao-Jiao; Yuan, Yun-Fei; Li, Yan; Guan, Xin-Yuan.
Afiliação
  • Zheng YL; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou 510062, China.
  • Li L; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou 510062, China.
  • Jia YX; Department of Clinical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
  • Zhang BZ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou 510062, China.
  • Li JC; The People's Hospital of Baoan Shenzhen, The Affiliated Baoan Hospital of Southern Medical University, Shenzhen 518101, China.
  • Zhu YH; Vascular Biology Research Institute, Guangdong Pharmaceutical University, Guangzhou 510006, China.
  • Li MQ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou 510062, China.
  • He JZ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou 510062, China.
  • Zeng TT; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China.
  • Ban XJ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou 510062, China.
  • Yuan YF; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou 510062, China.
  • Li Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou 510062, China.
  • Guan XY; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou 510062, China.
Theranostics ; 9(3): 796-810, 2019.
Article em En | MEDLINE | ID: mdl-30809309
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piruvato Quinase / Regulação Enzimológica da Expressão Gênica / Regulação Neoplásica da Expressão Gênica / Carcinoma Hepatocelular / RNA Longo não Codificante / Glucose / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Theranostics Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Austrália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piruvato Quinase / Regulação Enzimológica da Expressão Gênica / Regulação Neoplásica da Expressão Gênica / Carcinoma Hepatocelular / RNA Longo não Codificante / Glucose / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Theranostics Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Austrália